Skip to main content

Table 2 Clinical data of individuals included in cohort II

From: Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers

  NC, n = 7 AD, n = 16
Age (years) 78 ± 9 80 ± 11a
Females (%) 57 56
APOEε4 carriers (%) 14 69
PMD (h) 6.11 ± 1.30 6.06 ± 1.25a
  1. AD Alzheimer’s disease, APOE4 apolipoprotein 4, NC non-demented control, PMD postmortem delay
  2. aData were analysed using Student’s t-test, and values are presented as mean value ± SD
  3. *Significant at p ≤ 0.05 level
  4. **Significant at p ≤ 0.01 level
  5. ***Significant at p ≤ 0.001 level